Successful treatment of disseminated fusariosis [1]

Bone Marrow Transplantation

Volumn 31, Issue 5, 2003, Pages 411-412

  Rodriguez, C A ^a   Lujan Zilbermann J ^a   Woodard, P ^a   Andreansky, M ^a   Adderson, E E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CD34 ANTIGEN; CYTOCHROME P450; MEROPENEM; MYELOABLATIVE AGENT; VORICONAZOLE;

APLASTIC ANEMIA; BACILLUS CEREUS; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE REPORT; CELLULITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUSARIUM OXYSPORUM; GRAFT VERSUS HOST REACTION; GRANULOCYTE TRANSFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; JOINT BIOPSY; JOINT EFFUSION; LETTER; MICROBIOLOGICAL EXAMINATION; MYCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL;

AMPHOTERICIN B; CHILD, PRESCHOOL; FEMALE; FUSARIUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MYCOSES; PYRIMIDINES; TRIAZOLES;

EID: 0037357159     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703857     Document Type: Letter

References (7)

1. Girmenia C, Iori AP, Boecklin F et al. Fusarium infections in patients with severe aplastic anemia: review and implications for management. Haematologica 1999; 84: 114-118.
2. Espinel-Ingroff A. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol 1998; 36: 198-202.
3. Clancy CJ, Nguyen MH. In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species. Eur J Clin Microbiol Infect Dis 1998; 17: 573-575.
4. Radford SA, Johnson EM, Warnock DW. In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemother 1997; 41: 841-843.
5. Denning DW, Ribaud P, Milpied N et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002; 34: 563-571.
6. Walsh TJ, Pappas P, Winston DJ et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346: 225-234.
7. Walsh TJ, Lutsar I, Driscoll T et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 2002; 21: 240-248.